Capricor Therapeutics
CAPR
#7990
Rank
โ‚ฌ0.24 B
Marketcap
5,44ย โ‚ฌ
Share price
-4.36%
Change (1 day)
-61.47%
Change (1 year)

Capricor Therapeutics (CAPR) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.10 Billion

According to Capricor Therapeutics 's latest financial reports the company's total assets are โ‚ฌ0.10 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Capricor Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.16 B208.35%
2023-12-31โ‚ฌ53.13 M13.77%
2022-12-31โ‚ฌ46.7 M27.97%
2021-12-31โ‚ฌ36.49 M29.66%
2020-12-31โ‚ฌ28.14 M183.7%
2019-12-31โ‚ฌ9.92 M22.74%
2018-12-31โ‚ฌ8.08 M-40.4%
2017-12-31โ‚ฌ13.56 M-23.9%
2016-12-31โ‚ฌ17.82 M21.27%
2015-12-31โ‚ฌ14.69 M31.12%
2014-12-31โ‚ฌ11.2 M179.51%
2013-12-31โ‚ฌ4.01 M-2.2%
2012-12-31โ‚ฌ4.1 M288.05%
2011-12-31โ‚ฌ1.05 M-61.66%
2010-12-31โ‚ฌ2.75 M9.09%
2009-12-31โ‚ฌ2.52 M-45.12%
2008-12-31โ‚ฌ4.6 M-60.67%
2007-12-31โ‚ฌ11.7 M
2006-12-31N/A-100%
2005-12-31โ‚ฌ0 M-49.33%
2004-12-31โ‚ฌ0 M-45.38%
2003-12-31โ‚ฌ0 M3483.58%
2002-12-31โ‚ฌ0 M-91.31%
2001-12-31โ‚ฌ0 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Cytokinetics
CYTK
โ‚ฌ1.22 B 1,036.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ3.18 M-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ164.91 B 152,398.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ3.64 B 3,273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ0.55 B 412.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ5.27 M-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA